Global Infantile Spasms Therapeutics Supply, Demand and Key Producers, 2024-2030

Description

The global Infantile Spasms Therapeutics market size is expected to reach $ 185.2 million by 2030, rising at a market growth of 3.4% CAGR during the forecast period (2024-2030).

Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.

In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

This report studies the global Infantile Spasms Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Infantile Spasms Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infantile Spasms Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Infantile Spasms Therapeutics total market, 2019-2030, (USD Million)
Global Infantile Spasms Therapeutics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Infantile Spasms Therapeutics total market, key domestic companies and share, (USD Million)
Global Infantile Spasms Therapeutics revenue by player and market share 2019-2024, (USD Million)
Global Infantile Spasms Therapeutics total market by Type, CAGR, 2019-2030, (USD Million)
Global Infantile Spasms Therapeutics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Infantile Spasms Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin and GW Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infantile Spasms Therapeutics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Infantile Spasms Therapeutics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Infantile Spasms Therapeutics Market, Segmentation by Type
    Oral
    Injection

Global Infantile Spasms Therapeutics Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    Mallinckrodt
    H. Lundbeck
    Insys Therapeutics
    Orphelia Pharma
    Valerion Therapeutics
    Catalyst Pharmaceuticals
    Anavex Life Sciences
    Retrophin
    GW Pharmaceuticals

Key Questions Answered
1. How big is the global Infantile Spasms Therapeutics market?
2. What is the demand of the global Infantile Spasms Therapeutics market?
3. What is the year over year growth of the global Infantile Spasms Therapeutics market?
4. What is the total value of the global Infantile Spasms Therapeutics market?
5. Who are the major players in the global Infantile Spasms Therapeutics market?

Table of Contents

1 Supply Summary
    1.1 Infantile Spasms Therapeutics Introduction
    1.2 World Infantile Spasms Therapeutics Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Infantile Spasms Therapeutics Total Market by Region (by Headquarter Location)
        1.3.1 World Infantile Spasms Therapeutics Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.3 China Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.4 Europe Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.5 Japan Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.6 South Korea Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.7 ASEAN Infantile Spasms Therapeutics Market Size (2019-2030)
        1.3.8 India Infantile Spasms Therapeutics Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Infantile Spasms Therapeutics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Infantile Spasms Therapeutics Major Market Trends

2 Demand Summary
    2.1 World Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.2 World Infantile Spasms Therapeutics Consumption Value by Region
        2.2.1 World Infantile Spasms Therapeutics Consumption Value by Region (2019-2024)
        2.2.2 World Infantile Spasms Therapeutics Consumption Value Forecast by Region (2025-2030)
    2.3 United States Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.4 China Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.5 Europe Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.6 Japan Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.7 South Korea Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.8 ASEAN Infantile Spasms Therapeutics Consumption Value (2019-2030)
    2.9 India Infantile Spasms Therapeutics Consumption Value (2019-2030)

3 World Infantile Spasms Therapeutics Companies Competitive Analysis
    3.1 World Infantile Spasms Therapeutics Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Infantile Spasms Therapeutics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Infantile Spasms Therapeutics in 2023
        3.2.3 Global Concentration Ratios (CR8) for Infantile Spasms Therapeutics in 2023
    3.3 Infantile Spasms Therapeutics Company Evaluation Quadrant
    3.4 Infantile Spasms Therapeutics Market: Overall Company Footprint Analysis
        3.4.1 Infantile Spasms Therapeutics Market: Region Footprint
        3.4.2 Infantile Spasms Therapeutics Market: Company Product Type Footprint
        3.4.3 Infantile Spasms Therapeutics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Infantile Spasms Therapeutics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Infantile Spasms Therapeutics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Infantile Spasms Therapeutics Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Infantile Spasms Therapeutics Consumption Value Comparison
        4.2.1 United States VS China: Infantile Spasms Therapeutics Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Infantile Spasms Therapeutics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Infantile Spasms Therapeutics Companies and Market Share, 2019-2024
        4.3.1 United States Based Infantile Spasms Therapeutics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024)
    4.4 China Based Companies Infantile Spasms Therapeutics Revenue and Market Share, 2019-2024
        4.4.1 China Based Infantile Spasms Therapeutics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024)
    4.5 Rest of World Based Infantile Spasms Therapeutics Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Infantile Spasms Therapeutics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Infantile Spasms Therapeutics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Injection
    5.3 Market Segment by Type
        5.3.1 World Infantile Spasms Therapeutics Market Size by Type (2019-2024)
        5.3.2 World Infantile Spasms Therapeutics Market Size by Type (2025-2030)
        5.3.3 World Infantile Spasms Therapeutics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Infantile Spasms Therapeutics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Infantile Spasms Therapeutics Market Size by Application (2019-2024)
        6.3.2 World Infantile Spasms Therapeutics Market Size by Application (2025-2030)
        6.3.3 World Infantile Spasms Therapeutics Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Mallinckrodt
        7.1.1 Mallinckrodt Details
        7.1.2 Mallinckrodt Major Business
        7.1.3 Mallinckrodt Infantile Spasms Therapeutics Product and Services
        7.1.4 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Mallinckrodt Recent Developments/Updates
        7.1.6 Mallinckrodt Competitive Strengths & Weaknesses
    7.2 H. Lundbeck
        7.2.1 H. Lundbeck Details
        7.2.2 H. Lundbeck Major Business
        7.2.3 H. Lundbeck Infantile Spasms Therapeutics Product and Services
        7.2.4 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 H. Lundbeck Recent Developments/Updates
        7.2.6 H. Lundbeck Competitive Strengths & Weaknesses
    7.3 Insys Therapeutics
        7.3.1 Insys Therapeutics Details
        7.3.2 Insys Therapeutics Major Business
        7.3.3 Insys Therapeutics Infantile Spasms Therapeutics Product and Services
        7.3.4 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Insys Therapeutics Recent Developments/Updates
        7.3.6 Insys Therapeutics Competitive Strengths & Weaknesses
    7.4 Orphelia Pharma
        7.4.1 Orphelia Pharma Details
        7.4.2 Orphelia Pharma Major Business
        7.4.3 Orphelia Pharma Infantile Spasms Therapeutics Product and Services
        7.4.4 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Orphelia Pharma Recent Developments/Updates
        7.4.6 Orphelia Pharma Competitive Strengths & Weaknesses
    7.5 Valerion Therapeutics
        7.5.1 Valerion Therapeutics Details
        7.5.2 Valerion Therapeutics Major Business
        7.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Product and Services
        7.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Valerion Therapeutics Recent Developments/Updates
        7.5.6 Valerion Therapeutics Competitive Strengths & Weaknesses
    7.6 Catalyst Pharmaceuticals
        7.6.1 Catalyst Pharmaceuticals Details
        7.6.2 Catalyst Pharmaceuticals Major Business
        7.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Services
        7.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Catalyst Pharmaceuticals Recent Developments/Updates
        7.6.6 Catalyst Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Anavex Life Sciences
        7.7.1 Anavex Life Sciences Details
        7.7.2 Anavex Life Sciences Major Business
        7.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Product and Services
        7.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Anavex Life Sciences Recent Developments/Updates
        7.7.6 Anavex Life Sciences Competitive Strengths & Weaknesses
    7.8 Retrophin
        7.8.1 Retrophin Details
        7.8.2 Retrophin Major Business
        7.8.3 Retrophin Infantile Spasms Therapeutics Product and Services
        7.8.4 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Retrophin Recent Developments/Updates
        7.8.6 Retrophin Competitive Strengths & Weaknesses
    7.9 GW Pharmaceuticals
        7.9.1 GW Pharmaceuticals Details
        7.9.2 GW Pharmaceuticals Major Business
        7.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Product and Services
        7.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 GW Pharmaceuticals Recent Developments/Updates
        7.9.6 GW Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Infantile Spasms Therapeutics Industry Chain
    8.2 Infantile Spasms Therapeutics Upstream Analysis
    8.3 Infantile Spasms Therapeutics Midstream Analysis
    8.4 Infantile Spasms Therapeutics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Infantile Spasms Therapeutics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Infantile Spasms Therapeutics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Infantile Spasms Therapeutics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Infantile Spasms Therapeutics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Infantile Spasms Therapeutics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Infantile Spasms Therapeutics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Infantile Spasms Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Infantile Spasms Therapeutics Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Infantile Spasms Therapeutics Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Infantile Spasms Therapeutics Players in 2023
    Table 12. World Infantile Spasms Therapeutics Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Infantile Spasms Therapeutics Company Evaluation Quadrant
    Table 14. Head Office of Key Infantile Spasms Therapeutics Player
    Table 15. Infantile Spasms Therapeutics Market: Company Product Type Footprint
    Table 16. Infantile Spasms Therapeutics Market: Company Product Application Footprint
    Table 17. Infantile Spasms Therapeutics Mergers & Acquisitions Activity
    Table 18. United States VS China Infantile Spasms Therapeutics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Infantile Spasms Therapeutics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Infantile Spasms Therapeutics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Infantile Spasms Therapeutics Revenue Market Share (2019-2024)
    Table 23. China Based Infantile Spasms Therapeutics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Infantile Spasms Therapeutics Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Infantile Spasms Therapeutics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Infantile Spasms Therapeutics Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Infantile Spasms Therapeutics Revenue Market Share (2019-2024)
    Table 29. World Infantile Spasms Therapeutics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Infantile Spasms Therapeutics Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Infantile Spasms Therapeutics Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Infantile Spasms Therapeutics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Infantile Spasms Therapeutics Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Infantile Spasms Therapeutics Market Size by Application (2025-2030) & (USD Million)
    Table 35. Mallinckrodt Basic Information, Area Served and Competitors
    Table 36. Mallinckrodt Major Business
    Table 37. Mallinckrodt Infantile Spasms Therapeutics Product and Services
    Table 38. Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Mallinckrodt Recent Developments/Updates
    Table 40. Mallinckrodt Competitive Strengths & Weaknesses
    Table 41. H. Lundbeck Basic Information, Area Served and Competitors
    Table 42. H. Lundbeck Major Business
    Table 43. H. Lundbeck Infantile Spasms Therapeutics Product and Services
    Table 44. H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. H. Lundbeck Recent Developments/Updates
    Table 46. H. Lundbeck Competitive Strengths & Weaknesses
    Table 47. Insys Therapeutics Basic Information, Area Served and Competitors
    Table 48. Insys Therapeutics Major Business
    Table 49. Insys Therapeutics Infantile Spasms Therapeutics Product and Services
    Table 50. Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Insys Therapeutics Recent Developments/Updates
    Table 52. Insys Therapeutics Competitive Strengths & Weaknesses
    Table 53. Orphelia Pharma Basic Information, Area Served and Competitors
    Table 54. Orphelia Pharma Major Business
    Table 55. Orphelia Pharma Infantile Spasms Therapeutics Product and Services
    Table 56. Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Orphelia Pharma Recent Developments/Updates
    Table 58. Orphelia Pharma Competitive Strengths & Weaknesses
    Table 59. Valerion Therapeutics Basic Information, Area Served and Competitors
    Table 60. Valerion Therapeutics Major Business
    Table 61. Valerion Therapeutics Infantile Spasms Therapeutics Product and Services
    Table 62. Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Valerion Therapeutics Recent Developments/Updates
    Table 64. Valerion Therapeutics Competitive Strengths & Weaknesses
    Table 65. Catalyst Pharmaceuticals Basic Information, Area Served and Competitors
    Table 66. Catalyst Pharmaceuticals Major Business
    Table 67. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Services
    Table 68. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Catalyst Pharmaceuticals Recent Developments/Updates
    Table 70. Catalyst Pharmaceuticals Competitive Strengths & Weaknesses
    Table 71. Anavex Life Sciences Basic Information, Area Served and Competitors
    Table 72. Anavex Life Sciences Major Business
    Table 73. Anavex Life Sciences Infantile Spasms Therapeutics Product and Services
    Table 74. Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Anavex Life Sciences Recent Developments/Updates
    Table 76. Anavex Life Sciences Competitive Strengths & Weaknesses
    Table 77. Retrophin Basic Information, Area Served and Competitors
    Table 78. Retrophin Major Business
    Table 79. Retrophin Infantile Spasms Therapeutics Product and Services
    Table 80. Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Retrophin Recent Developments/Updates
    Table 82. GW Pharmaceuticals Basic Information, Area Served and Competitors
    Table 83. GW Pharmaceuticals Major Business
    Table 84. GW Pharmaceuticals Infantile Spasms Therapeutics Product and Services
    Table 85. GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 86. Global Key Players of Infantile Spasms Therapeutics Upstream (Raw Materials)
    Table 87. Infantile Spasms Therapeutics Typical Customers
List of Figure
    Figure 1. Infantile Spasms Therapeutics Picture
    Figure 2. World Infantile Spasms Therapeutics Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Infantile Spasms Therapeutics Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Infantile Spasms Therapeutics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Infantile Spasms Therapeutics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Infantile Spasms Therapeutics Revenue (2019-2030) & (USD Million)
    Figure 13. Infantile Spasms Therapeutics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Infantile Spasms Therapeutics Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Infantile Spasms Therapeutics Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Infantile Spasms Therapeutics by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Infantile Spasms Therapeutics Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Infantile Spasms Therapeutics Markets in 2023
    Figure 27. United States VS China: Infantile Spasms Therapeutics Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Infantile Spasms Therapeutics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Infantile Spasms Therapeutics Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Infantile Spasms Therapeutics Market Size Market Share by Type in 2023
    Figure 31. Oral
    Figure 32. Injection
    Figure 33. World Infantile Spasms Therapeutics Market Size Market Share by Type (2019-2030)
    Figure 34. World Infantile Spasms Therapeutics Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Infantile Spasms Therapeutics Market Size Market Share by Application in 2023
    Figure 36. Hospital
    Figure 37. Clinic
    Figure 38. Other
    Figure 39. Infantile Spasms Therapeutics Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals